• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者的心房颤动与心脏性猝死风险——一项全国性队列研究

Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study.

作者信息

Liao Min-Tsun, Wu Cho-Kai, Juang Jyh-Ming Jimmy, Lin Ting-Tse, Wu Chih-Cheng, Lin Lian-Yu

机构信息

Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu City 300, Taiwan.

College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

EClinicalMedicine. 2021 Mar 17;34:100802. doi: 10.1016/j.eclinm.2021.100802. eCollection 2021 Apr.

DOI:10.1016/j.eclinm.2021.100802
PMID:33997728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8102675/
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM), affecting 0.2% of the population, is the leading cause of sudden cardiac arrest (SCA). Incident atrial fibrillation (AF) is associated with an increased risk of SCA in general population. To determine whether AF is associated with an increased risk of SCA in patients with HCM.

METHODS

This nationwide cohort study analyzed data from Registry for Catastrophic Illness, which encompassed almost 100% of the patients with HCM in Taiwan from 1996 to 2013. Follow-up and data analysis ended December 31, 2013. The main outcome was physician-adjudicated SCA, defined as death from a sudden, pulseless condition presumed due to a ventricular tachyarrhythmia. The secondary outcome was non-sudden cardiac death (NSCD), which was heart failure death, stroke death and non-HCM related death. We used Cox proportional hazards models to assess the association between AF and SCA/NSCD, adjusting for baseline demographic and cardiovascular risk factors.

FINDINGS

A total 10,910 subjects participated in this study with mean age of 62 years. Among enrolled subjects, 1,169 (10.7%) developed AF, which was independently associated with elder age, female sex, and history of heart failure (HF) hospitalization. During follow-up (median, 8.5 years and 2th to 7th interquartile range, 3.6 to 16.5 years), 371 SCA (166 in AF and 205 in non-AF group) and 797 NSCD (417 in AF and 380 in non-AF group) events occurred. The crude incidence rates of SCA were 12.45/1000 person-years (with AF) and 3.57/1000 person-years (without AF). The crude incidence rates for NSCD were 31.29/1000 person-years (with AF) and 6.63/1000 person-years (without AF). The multivariable hazard ratios (HRs) (95% CI) of AF for SCA and NSCD were 3.633 (2.756-4.791) and 2.086 (1.799-2.418), respectively. Furthermore, among the etiologies of NSCD, subjects with AF was at most risk of stroke-related death (HR, 6.609; 95% CI, 3.794-9.725).

INTERPRETATION

Incident AF is associated with an increased risk of SCA and NSCD in the HCM population. Early detection of AF may provide more comprehensive risk stratification of SCD in HCM population. Because of underuse of oral anticoagulants and the absence of primary prevention ICD therapy in our cohort, the application of our findings was limited for the general HCM population in the current clinical practice.

FUNDING

None.

摘要

背景

肥厚型心肌病(HCM)影响0.2%的人群,是心脏性猝死(SCA)的主要原因。在普通人群中,新发心房颤动(AF)与SCA风险增加相关。旨在确定AF是否与HCM患者SCA风险增加相关。

方法

这项全国性队列研究分析了重大伤病登记处的数据,该登记处涵盖了1996年至2013年台湾几乎所有HCM患者。随访和数据分析于2013年12月31日结束。主要结局是经医生判定的SCA,定义为因假定由室性快速心律失常导致的突发、无脉状态而死亡。次要结局是非心脏性猝死(NSCD),即心力衰竭死亡、中风死亡和非HCM相关死亡。我们使用Cox比例风险模型评估AF与SCA/NSCD之间的关联,并对基线人口统计学和心血管危险因素进行了调整。

结果

共有10910名受试者参与本研究,平均年龄为62岁。在纳入的受试者中,1169名(10.7%)发生了AF,其与老年、女性性别和心力衰竭(HF)住院史独立相关。在随访期间(中位数为8.5年,第2至第7四分位数间距为3.6至16.5年),发生了371例SCA事件(AF组166例,非AF组205例)和797例NSCD事件(AF组417例,非AF组380例)。SCA的粗发病率分别为12.45/1000人年(有AF)和3.57/1000人年(无AF)。NSCD的粗发病率分别为31.29/1000人年(有AF)和6.63/1000人年(无AF)。AF对SCA和NSCD的多变量风险比(HRs)(95%CI)分别为3.633(2.756 - 4.791)和2.086(1.799 - 2.418)。此外,在NSCD的病因中,AF患者发生中风相关死亡的风险最高(HR,6.609;95%CI,3.794 - 9.725)。

解读

新发AF与HCM人群中SCA和NSCD风险增加相关。AF的早期检测可能为HCM人群中SCD提供更全面的风险分层。由于我们队列中口服抗凝剂使用不足以及缺乏一级预防ICD治疗,在当前临床实践中,我们研究结果的应用在一般HCM人群中受到限制。

资助

无。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/069a808f1373/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/129840c51424/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/e792f672bf9d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/069a808f1373/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/129840c51424/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/e792f672bf9d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569b/8102675/069a808f1373/gr3.jpg

相似文献

1
Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study.肥厚型心肌病患者的心房颤动与心脏性猝死风险——一项全国性队列研究
EClinicalMedicine. 2021 Mar 17;34:100802. doi: 10.1016/j.eclinm.2021.100802. eCollection 2021 Apr.
2
Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study.心房颤动与心源性猝死风险:动脉粥样硬化风险社区研究与心血管健康研究。
JAMA Intern Med. 2013 Jan 14;173(1):29-35. doi: 10.1001/2013.jamainternmed.744.
3
Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者新发心房颤动的临床意义。
ESC Heart Fail. 2021 Dec;8(6):5022-5030. doi: 10.1002/ehf2.13563. Epub 2021 Sep 2.
4
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.合并症对肥厚型心肌病中心律失常和心源性猝死的影响。
J Cardiovasc Electrophysiol. 2022 Jan;33(1):20-29. doi: 10.1111/jce.15304. Epub 2021 Dec 8.
5
Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study.无房颤的肥厚型心肌病患者发生缺血性卒中的风险——一项全国性队列研究
Aging (Albany NY). 2019 Dec 2;11(23):11347-11357. doi: 10.18632/aging.102532.
6
Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.肥厚型心肌病中心律失常的预后影响:系统评价。
Clin Res Cardiol. 2021 Apr;110(4):544-554. doi: 10.1007/s00392-020-01730-w. Epub 2020 Sep 3.
7
Understanding the incidence of atrial fibrillation and stroke in hypertrophic cardiomyopathy patients: insights from Danish nationwide registries.了解肥厚型心肌病患者心房颤动和中风的发生率:来自丹麦全国登记处的见解。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae177.
8
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.非维生素 K 拮抗剂口服抗凝剂在伴有肥厚型心肌病的心房颤动患者中的有效性和安全性:一项全国性队列研究。
Chest. 2019 Feb;155(2):354-363. doi: 10.1016/j.chest.2018.11.009. Epub 2018 Nov 22.
9
Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.泰国成年肥厚型心肌病患者的死亡模式和临床结局。
BMC Cardiovasc Disord. 2019 Jan 3;19(1):1. doi: 10.1186/s12872-018-0984-0.
10
Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation.肥厚型心肌病患者伴或不伴心房颤动时左心房增大与猝死风险
J Cardiol. 2016 Dec;68(6):478-484. doi: 10.1016/j.jjcc.2016.01.006. Epub 2016 Feb 20.

引用本文的文献

1
Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities.肥厚型心肌病管理中的综合方法:当前治疗方式的全面综述
Biomedicines. 2025 May 21;13(5):1256. doi: 10.3390/biomedicines13051256.
2
Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中的心房颤动
JACC Adv. 2024 Aug 20;3(9):101210. doi: 10.1016/j.jacadv.2024.101210. eCollection 2024 Sep.
3
Impact of rs1805127 and rs55742440 Variants on Atrial Remodeling in Hypertrophic Cardiomyopathy Patients with Atrial Fibrillation: A Romanian Cohort Study.

本文引用的文献

1
Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study.无房颤的肥厚型心肌病患者发生缺血性卒中的风险——一项全国性队列研究
Aging (Albany NY). 2019 Dec 2;11(23):11347-11357. doi: 10.18632/aging.102532.
2
C HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.CHEST 评分与中风后患者心房颤动事件的预测:一项法国全国性研究。
J Am Heart Assoc. 2019 Jul 2;8(13):e012546. doi: 10.1161/JAHA.119.012546. Epub 2019 Jun 25.
3
Taiwan's National Health Insurance Research Database: past and future.
rs1805127 和 rs55742440 变异对伴心房颤动的肥厚型心肌病患者心房重构的影响:一项罗马尼亚队列研究。
Int J Mol Sci. 2023 Dec 8;24(24):17244. doi: 10.3390/ijms242417244.
4
Prognostic effect of atrial fibrillation on survival in patients with hypertrophic cardiomyopathy: a meta-analysis.心房颤动对肥厚型心肌病患者生存预后的影响:一项荟萃分析。
J Cardiothorac Surg. 2023 Jun 20;18(1):196. doi: 10.1186/s13019-023-02299-x.
5
Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator.更新植入式心律转复除颤器肥厚型心肌病患者心源性猝死的风险评估。
Korean J Intern Med. 2023 Jan;38(1):7-15. doi: 10.3904/kjim.2022.144. Epub 2022 Nov 10.
台湾全民健康保险研究数据库:过去与未来。
Clin Epidemiol. 2019 May 3;11:349-358. doi: 10.2147/CLEP.S196293. eCollection 2019.
4
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction.缺血性心脏病改变了射血分数降低的心力衰竭中房颤与死亡率的关联。
J Am Heart Assoc. 2018 Oct 16;7(20):e009770. doi: 10.1161/JAHA.118.009770.
5
Clinical Course and Management of Hypertrophic Cardiomyopathy.肥厚型心肌病的临床病程与管理
N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.
6
Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.肥厚型心肌病中的心房颤动:旧问题的新见解。
Circulation. 2017 Dec 19;136(25):2437-2439. doi: 10.1161/CIRCULATIONAHA.117.031743.
7
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.肥厚型心肌病中心房颤动的临床特征和后果。
Circulation. 2017 Dec 19;136(25):2420-2436. doi: 10.1161/CIRCULATIONAHA.117.029267. Epub 2017 Sep 15.
8
Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.心房颤动对心尖肥厚型心肌病临床病程的影响。
Heart. 2017 Oct;103(19):1496-1501. doi: 10.1136/heartjnl-2016-310720. Epub 2017 Apr 20.
9
Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study.房颤患者心脏性猝死和室性心律失常的风险和预测 - 一项全国性队列研究。
Sci Rep. 2017 Apr 19;7:46445. doi: 10.1038/srep46445.
10
Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.肥厚型心肌病合并除颤器患者的室性快速心律失常:触发因素、治疗及意义
J Cardiovasc Electrophysiol. 2017 May;28(5):531-537. doi: 10.1111/jce.13194. Epub 2017 Mar 31.